Keyphrases
Metabolic Profiling
100%
Untargeted
100%
Lipidomic Profiling
100%
Metabolic-associated Fatty Liver Disease (MAFLD)
100%
Plasma Metabolomics
100%
Plasma Lipidomics
100%
Multiplatform Approaches
100%
Amino Acid Metabolism
18%
Environmental Factors
9%
Metabolism
9%
Therapeutic Strategies
9%
Therapeutic Potential
9%
Dysregulation
9%
Diagnostic Strategy
9%
Genetic Predisposition
9%
Obese Patients
9%
Liver Biopsy
9%
Disease Pathogenesis
9%
Hepatic Fibrosis
9%
Hepatic Inflammation
9%
Lipid Metabolism
9%
Liver Function
9%
Related Disorders
9%
Complex Disorders
9%
Energy Metabolism
9%
Liver Damage
9%
Arachidonic Acid Metabolism
9%
Biological Pathways
9%
Metabolic Pathway
9%
Hepatic Steatosis
9%
NMR Spectroscopy
9%
Fatty Acid Metabolism
9%
Mitochondrial Dysfunction
9%
Metabolic Alterations
9%
Liquid Chromatography-high Resolution Mass Spectrometry (LC-HRMS)
9%
Omics
9%
Steroid Metabolism
9%
Amino Lipid
9%
Bile Acid Metabolism
9%
Metabolome-wide Association Study
9%
Plasma Lipidome
9%
Carnitine Shuttle
9%
Glycerophospholipid Metabolism
9%
Metabolic Syndrome Factors
9%
Immune System Disorder
9%
Metabolic Pathway Enrichment Analysis
9%
Immunology and Microbiology
Blood Plasma
100%
Metabolome
100%
Metabolism
100%
Amino Acid Metabolism
100%
Metabolite
50%
Nuclear Magnetic Resonance Spectroscopy
50%
Genetic Predisposition
50%
Lipid Metabolism
50%
Liver Function
50%
Animal Experiment
50%
Fatty Acid Metabolism
50%
Energy Metabolism
50%
Arachidonic Acid Metabolism
50%
Bile Acid Metabolism
50%
Steroid Metabolism
50%
Immune System Disorders
50%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
Metabolomics
100%
Lipidomics
100%
Blood Plasma
100%
Metabolome
50%
Amino Acid Metabolism
50%
Animal Experiment
25%
Metabolite
25%
Genetic Predisposition
25%
Lipid Metabolism
25%
Liver Function
25%
Energy Metabolism
25%
Fatty Acid Metabolism
25%
Immunity
25%
Arachidonic Acid Metabolism
25%
Steroid Metabolism
25%
Resolution (Mass Spectrometry)
25%
Lipidome
25%
Carnitine Shuttle
25%
Mitochondrial Disorder
25%
Bile Acid Metabolism
25%
Tamsulosin
25%
Glycerophospholipid
25%
Nuclear Magnetic Resonance Spectroscopy
25%
Medicine and Dentistry
Metabolomics
100%
Non-Alcoholic Fatty Liver Disease
100%
Lipidomics
100%
Metabolism
18%
Metabolome
18%
Amino Acid Metabolism
18%
Diseases
18%
Diagnosis
9%
Metabolite
9%
Liver Injury
9%
Genetic Predisposition
9%
Metabolic Syndrome
9%
Liver Biopsy
9%
Liver Fibrosis
9%
Lipid Metabolism
9%
Liver Function
9%
Environmental Factor
9%
Human Study
9%
Tamsulosin
9%
Fatty Liver
9%
Immune Disorder
9%
Mass Spectrum
9%
Energy Metabolism
9%
Fatty Acid Metabolism
9%
Glycerophospholipid
9%
Steroid Metabolism
9%
Arachidonic Acid Metabolism
9%
Carnitine
9%
Lipidome
9%
Bile Acid Metabolism
9%
Mitochondrial Disorder
9%
NMR Spectroscopy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Liver
100%
Amino Acid
16%
Diseases
16%
Inflammation
8%
Fatty Acid
8%
Liver Injury
8%
Metabolic Syndrome X
8%
Genetic Predisposition
8%
Liver Fibrosis
8%
Arachidonic Acid
8%
Carnitine
8%
Bile Acid
8%
Tamsulosin
8%
Glycerophospholipid
8%
Lipidome
8%